PASG
$4.40-0.17 (-3.72%)
Market OpenUpdated 11:40 AM EDT
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases.
$4.40-0.17 (-3.72%)
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases.